Analyst Ratings for Zentalis Pharmaceuticals (ZNTL)
ZNTL Rating Summary
ZNTL Price Target Summary
- Highest: $10.00 (Guggenheim)
- Lowest: $2.00 (Leerink)
- Average: $6.57
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.57 (+82.5%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 52%
Avg. $ Target:
$6.57 (+82.5%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 52%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/17/2026 | Wells Fargo | Eva Fortea Verdejo | New Coverage | Equal Weight (N/A) |
5.00 (N/A) |
2.71 (3.60) |
32.84% | Details |
| 8/12/2024 | Wedbush | Robert Driscoll | Upgrade | Neutral (Underperform) |
4.00 (N/A) |
3.00 (3.60) |
20% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
